spacer gif spacer gif spacer gif spacer gif spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

First published online 28 November 2007
doi: 10.1242/dev.004713


Development 135, 75-84 (2008)
Published by The Company of Biologists 2008


This Article
Right arrow Summary Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Material
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in Development
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schneider, I.
Right arrow Articles by Slusarski, D. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schneider, I.
Right arrow Articles by Slusarski, D. C.

Calcium fluxes in dorsal forerunner cells antagonize β-catenin and alter left-right patterning

Igor Schneider1, Douglas W. Houston1, Michael R. Rebagliati2 and Diane C. Slusarski1,*

1 Department of Biological Sciences, University of Iowa, Iowa City, IA 52242, USA.
2 Department of Anatomy and Cell Biology, University of Iowa, Iowa City, IA 52242, USA.


Figure 1
View larger version (41K):
[in this window]
[in a new window]

 
Fig. 1. Ca2+ manipulation impacts organ laterality. (A-C) Lateral view, dorsal to the right of 70-80% epiboly stage embryos with arrows indicating the DFC region in (A) bright field image, (B) an individual frame of Fura-2 (380) fluorescence and (C) the corresponding ratiometric image (340/380). The ratio image is converted to pseudo-color with yellow indicating high free intracellular Ca2+. (D) Summary plot of thapsigargin exposure vs heart jogging defects. (E) Summary of heart jogging defects in wt, control and after 10 and 20 minutes of thapsigargin treatment at 60% epiboly. Lateral view of wt (F) and thapsigargin-treated (G) embryos. (H) Summary of organ laterality defects. Thap, thapsigargin.

 

Figure 2
View larger version (61K):
[in this window]
[in a new window]

 
Fig. 2. Thapsigargin treatment disrupts organ laterality and molecular asymmetry. (A-C) Dorsal view, 30 hpf, showing nkx2.5 expression in the heart tube, denoting a left jog in wt (A), and no jog (B) or right jog (C) in thapsigargin-treated embryos. (D-F) Dorsal view, 48 hpf, white arrows indicate foxA3 gut expression in wt (D) and symmetrical (E) or reverse loop (F) in thapsigargin-treated embryos. (G-I) Dorsal view, 19-23 somites, arrows indicate left-sided spaw expression in (G) wt, and (H) bilateral or (I) right-sided expression in thapsigargin-treated. Dorsal view, 19-23 somites, arrows indicate LPM, dashed arrows indicate brain lefty1 expression on the left side in (J) wt, and (K) bilateral in thapsigargin-treated, arrowheads denote lefty1 expression in the midline. Lateral view of ntl expression in (L) wt and (M) thapsigargin-treated, and shh expression in (N) wt and (O) thapsigargin-treated embryos. (P) Summary of asymmetrical marker expression.

 

Figure 3
View larger version (79K):
[in this window]
[in a new window]

 
Fig. 3. The DFCs are specified and migrate to the tailbud in thapsigargin-treated embryos. sox17 expression at 80% epiboly in (A) wt and (B) thapsigargin-treated embryos. Enriched Ntl protein at 80% epiboly in the DFCs in (C) wt and (D) thapsigargin-treated embryos; arrowheads note the DFC region. Expression of sox17 at 4-5 somites in (E) wt and (F) XeC-treated embryos; asterisks indicate dispersed cells, arrows indicate DFC/KV region. Tg (Dusp6:d2EGFP) expression at 80% epiboly in (G) untreated and (H) thapsigargin-treated embryos; arrows indicate DFCs. EGFP expression at tailbud to 1-somite in (I) untreated and (J) thapsigargin-treated embryos and at 5 somites in (K) untreated and (L) thapsigargin-treated embryos. XeC, Xestospongin C; n, notochord.

 

Figure 4
View larger version (77K):
[in this window]
[in a new window]

 
Fig. 4. DFC regional Ca2+ is required for KV morphogenesis. (A) Summary of KV defects. (B-D) Bright field image of wt embryo with normal KV (B) and thapsigargin-treated with reduced (C) and absent (D) KV: dorsal view, 10 somites. Arrows indicate vesicle location; n, notochord. (E-G) charon expression (arrows) around KV in wt (E) and thapsigargin-treated embryos with reduced (F) and absent (G) signal: lateral view, 10 somites. Insets show dorsal view of charon expression. Thap, thapsigargin. Scale bars: 50 µm.

 

Figure 5
View larger version (79K):
[in this window]
[in a new window]

 
Fig. 5. Ca2+ inhibition activates β-catenin and β-catenin is sufficient to alter laterality. Confocal images of β-catenin immunolocalization at 70-80% epiboly in (A) wt and (B) thapsigargin-treated embryos. HRP staining of β-catenin protein oriented on the DFC region in (C) wt, (D) thapsigargin-treated and (E) DFC-targeted Axin-1 MO-injected embryos; arrowheads indicate β-catenin-positive nuclei. (F) Comparison of total nuclear β-catenin in wt and thapsigargin-treated embryos.* indicates P-value of 2.5x10-5. (G) TopFlash (top) vs. FopFlash (fop) luciferase reporter constructs analyzed for relative luminescence in wt or thapsigargin-treated embryos, normalized to control (Renilla) luciferase. Data are means ± s.e. (H,I) Combined lefty1 and lefty2 expression (arrows) in the left LPM and brain in wt (H) and bilateral (I) in DFC-targeted β-catenin RNA-injected embryos: dorsal-anterior view, 19-23 somites.

 

Figure 6
View larger version (79K):
[in this window]
[in a new window]

 
Fig. 6. Xenopus DFC-like cells and Ca2+ requirement for laterality. Xenopus embryos incubated with Syto-11 at stage 11.5 and sagittally bisected at (A) stage 14 and (B) stage 17 showing Syto-11-labeled cells enriched in the future tail region. (C) Stage 17 archenteron roof explant, showing Syto-11 staining of the node (arrow) and surrounding LPM. (D) Explant in C immunostained for acetylated tubulin (acTub), which is enriched in the node region (arrow). (E) Ventral view of stage 46 control-treated embryo, showing situs solitus, or normal lateral asymmetry. The heart is outlined, showing the left-sided position of the ventricle and right-sided outflow tract. The gut coils counterclockwise, as shown by the arrow. (F) Ventral view of a thapsigargin-treated embryo at stage 46, showing an example of situs inversus, or reversed laterality. The heart is outlined, showing the right-sided position of the ventricle and left-sided outflow tract. The gut coils clockwise, as shown by the arrow. (G) Left-sided xnr1 expression at stage 22-24 in a DMSO-treated embryo. (H) Bilateral xnr1 expression in a thapsigargin-treated embryo. (I,J) Lateral view of β-catenin protein localization in control-treated (I) and thapsigargin-treated (J) stage 13 embryos. Note increased number and intensity of nuclear staining. (K,L) Lateral views of control (K) and thapsigargin-treated (L) embryos, showing normal axial development. (M) Summary of Xenopus laterality data. Thap, thapsigargin.

 





© The Company of Biologists Ltd 2008